CellWell record HH-421662
A putative SGLT-relevant mechanistic perspective on quercetin-3-O-glucoside and rutin in diabetic kidney disease
Dante Saksono Harbuwono; Yulia Wardhani; Edwin Hadinata; Siti Nur Rohmah; Adha Fauzi Hendrawan; Ade Meidian Ambari; Metalia Puspitasari; Danny Pratama Kuswadi; Pringgodigdo Nugroho; Eka Ginanjar; Raymond Rubianto Tjandrawinata; Fahrul Nurkolis
2026
In plain language
This narrative review found that quercetin-3-O-glucoside and rutin may act on SGLT-related pathways in diabetic kidney disease, but direct inhibition of human SGLT2 has not been experimentally shown.
- Evidence
- Emerging
- Design
- Expert review
Cite this record: https://thecellwell.org/studies/HH-421662
Produced by the CellWell Research Engine, custom software owned and operated by CellWell. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.